ArticleACS omega2025
Hydrogel Based on Decellularized Bovine Trabecular Extracellular Matrix Enriched with Type I Collagen.
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Biomaterials are increasingly important in addressing the demand for biomimetic, biocompatible, and biodegradable materials for tissue replacement, treatment, or coexistence. Biocomposites enhance chemical and mechanical properties, supporting biological integration and mechanical stability at implantation sites. This study aimed to develop a thermosensitive biocomposite hydrogel using a decellularized extracellular matrix (ECM) from bovine trabecular bone and type I collagen from bovine tendon. Tendon-derived collagen increased total collagen concentration, improving cross-linking. Bovine bones were fragmented, decellularized, lyophilized, and pulverized. Type I collagen was extracted from tendons via solubilization in acetic acid, salt precipitation, and dialysis. ECM digestion was conducted in 0.01 N HCl with pepsin (1:10 ratio) at 37 °C for 96 h. The final collagen concentration was set at 10 mg/mL, with ECM-to-tendon collagen at a 1:10 ratio. Gelation was induced by temperature and pH changes. The ECM-collagen solution was neutralized (pH 7.0-7.6) using 0.1 M NaOH (1/10 digestion volume) and 10× PBS (1/9 digestion volume) to form a pregel, which was incubated at 37 °C for gelation. Gelation time, analyzed by turbidimetry at 405 nm, showed completion in ∼50 min. Collagen incorporation was 96.7%, while glycosaminoglycans (GAGs) incorporation reached 109%. Scanning electron microscopy (SEM) confirmed a porous, reticulated structure. These results indicate the successful incorporation of bone ECM components, thermosensitivity, and potential for Tissue Engineering and Regenerative Medicine applications in bone repair.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.